Join global leaders and innovators in oncology at ICTO 2027, shaping the future of cancer treatment and research from London to the world. The 10th Edition of International Conference on Clinical & Translational Oncology (ICTO 2027) will be held from September 27-29, 2027, in London, UK, with options for both in-person and virtual participation. Under the theme “From Prevention to Survivorship: A Cancer Care Continuum”, the conference provides an unparalleled platform for collaboration, knowledge exchange, and showcasing the latest advancements in oncology.
Leading oncologists, researchers, clinicians, healthcare professionals, industry innovators, and policymakers will come together at ICTO 2027, fostering interdisciplinary dialogue and partnerships. The conference creates a dynamic environment for exploring emerging trends, innovative solutions, and strategies to tackle cancer on a global scale.
The agenda covers a wide spectrum of topics including molecular oncology, immunotherapy, precision medicine, cancer genetics, clinical trials, and emerging therapeutic technologies. ICTO 2027 will examine both foundational research and translational applications, offering a comprehensive view of the rapidly evolving oncology landscape.
Participants will have the opportunity to present original research, case studies, and innovative methodologies through oral presentations, poster sessions, panel discussions, and interactive workshops. These sessions are designed to stimulate collaboration, critical discussion, and highlight pioneering approaches in cancer prevention, diagnosis, and treatment.
In summary, ICTO 2027 promises to unite experts from around the globe in advancing cancer research, improving patient outcomes, and fostering innovation in oncology. We look forward to welcoming you to London, UK, or virtually, as we embark on this exceptional journey of discovery, learning, and collaboration.
